Insider Transactions in Q1 2023 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
29,048
-0.41%
|
$871,440
$30.45 P/Share
|
|
Mar 28
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-1.4%
|
$3,000,000
$30.37 P/Share
|
|
Mar 27
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
60,964
-0.43%
|
$1,828,920
$30.53 P/Share
|
|
Mar 21
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
63,448
-0.44%
|
$1,966,888
$31.93 P/Share
|
|
Mar 16
2023
|
Justin B. Klee Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+1.73%
|
-
|
|
Mar 16
2023
|
Justin B. Klee Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-1.73%
|
$3,200,000
$32.16 P/Share
|
|
Mar 16
2023
|
Gina Mazzariello Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,333
+24.75%
|
-
|
|
Mar 16
2023
|
Patrick D Yeramian Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,167
+5.46%
|
-
|
|
Mar 16
2023
|
Patrick D Yeramian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
54,627
-13.57%
|
$1,748,064
$32.14 P/Share
|
|
Mar 16
2023
|
George M Milne Jr |
SELL
Open market or private sale
|
Direct |
35,000
-1.96%
|
$1,120,000
$32.16 P/Share
|
|
Mar 16
2023
|
Margaret Olinger Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,333
+7.3%
|
-
|
|
Mar 16
2023
|
Joshua B Cohen Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+1.73%
|
-
|
|
Mar 16
2023
|
Joshua B Cohen Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-1.73%
|
$3,200,000
$32.15 P/Share
|
|
Mar 16
2023
|
Karen Firestone |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$31,000
$31.99 P/Share
|
|
Mar 16
2023
|
James M Frates Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,667
+48.32%
|
-
|
|
Mar 16
2023
|
James M Frates Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
32,500
-71.79%
|
$1,040,000
$32.16 P/Share
|
|
Mar 16
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,122
-0.13%
|
$291,904
$32.55 P/Share
|
|
Mar 15
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-1.02%
|
$4,950,000
$33.4 P/Share
|
|
Mar 14
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
70,714
-0.95%
|
$2,404,276
$34.54 P/Share
|
|
Mar 02
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.66%
|
$1,650,000
$33.75 P/Share
|
|
Feb 24
2023
|
Gina Mazzariello Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,586
-8.75%
|
$121,924
$34.49 P/Share
|
|
Feb 23
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.33%
|
$1,750,000
$35.9 P/Share
|
|
Feb 22
2023
|
Morningside Venture Investments LTD > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-0.33%
|
$3,500,000
$35.57 P/Share
|
|
Jan 06
2023
|
James M Frates Chief Financial Officer |
BUY
Open market or private sale
|
Direct |
2,658
+3.68%
|
$95,688
$36.44 P/Share
|
|
Jan 06
2023
|
Joshua B Cohen Co-Chief Executive Officer |
BUY
Open market or private sale
|
Direct |
5,968
+0.1%
|
$214,848
$36.44 P/Share
|
|
Jan 06
2023
|
Patrick D Yeramian Chief Medical Officer |
BUY
Open market or private sale
|
Direct |
2,034
+0.49%
|
$73,224
$36.44 P/Share
|
|
Jan 06
2023
|
Justin B. Klee Co-Chief Executive Officer |
BUY
Open market or private sale
|
Direct |
5,968
+0.1%
|
$214,848
$36.44 P/Share
|
|
Jan 06
2023
|
Margaret Olinger Chief Commercial Officer |
BUY
Open market or private sale
|
Direct |
2,403
+0.56%
|
$86,508
$36.44 P/Share
|